Product Program year 2025 Source: CMS Open Payments

True Flow

Device Vascular/Oncology

PDI 00801741097683

Open in the dashboard

General payments

$72,350

96 payments

Research payments

$0

0 payments

Through program year 2025, $72,350 in general payments and $0 in research payments were reported against True Flow (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $1,800 49
2024 General $70,391 41
2023 General $158 6

Breakdown

Who paid General payments · program years 2023–2025
  1. Davol Inc. $68,723 1 payment
  2. Bard Peripheral Vascular, Inc. $2,633 63 payments
  3. Becton, Dickinson and Company $993 32 payments
Top recipients General payments · program year 2025
  1. Pedro Villablanca Spinetto Cardiovascular Disease · Detroit, MI $145 8% · 1 payment
  2. Rommel Yap Interventional Cardiology · Detroit, MI $145 8% · 1 payment
  3. Arturo Giacaman Saavedra Interventional Cardiology · Detroit, MI $145 8% · 1 payment
  4. Nishant Sethi Interventional Cardiology · Scranton, PA $101 6% · 1 payment
  5. Neville Mistry Interventional Cardiology · Las Vegas, NV $92 5% · 1 payment

The top 5 of 47 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $1,110 62% · 23 practitioners
  2. Cardiovascular Disease Internal Medicine $248 14% · 6 practitioners
  3. Vascular & Interventional Radiology Radiology $87 5% · 3 practitioners
  4. Nurse Practitioner, Acute Care Nurse Practitioner $70 4% · 3 practitioners
  5. Physician Assistant $62 3% · 1 practitioner

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Michigan $509 28% · 5 recipients
  2. California $342 19% · 12 recipients
  3. Nevada $184 10% · 2 recipients
  4. Idaho $173 10% · 5 recipients
  5. Oregon $113 6% · 3 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

96 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record